NeuroOne Medical Technologies Corp (NAS:NMTC)
$ 0.905 -0.035 (-3.72%) Market Cap: 27.89 Mil Enterprise Value: 27.40 Mil PE Ratio: 0 PB Ratio: 8.23 GF Score: 49/100

Neuroone Medical Technologies Corp at Noble Capital Markets Investor Conference (Virtual) Transcript

Apr 21, 2022 / 03:30PM GMT
Release Date Price: $1.03 (-0.69%)
Dave Rosa
NeuroOne Medical Technologies Corporation - President & CEO

Good morning, everyone. Thanks for joining me at the NobleCon Conference. My name is Dave Rosa. I'm the CEO of NeuroOne Medical Technologies Corporation. We are a NASDAQ-listed company in the field of neurology. I'm going to put up here just the forward-looking statement because we are a public company. I'm sure you've all seen that many times.

So in terms of what NeuroOne does, as I mentioned, we're a company in the neurology, space as well as neurosurgery, and we make electrodes that are used for neurosurgical procedures. So everything from epilepsy to Parkinson's disease.

One of the newer fields is depression, back pain due to failed back surgeries, multiple failed back surgeries. And there's many other indications that we're not focused on right now, but from a platform standpoint, would apply. Urinary incontinence is certainly one of them. High blood pressure is another.

What these devices do, just to be clear, is they perform multiple functions. So in the brain, what they'll do is record

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot